Skip to main content
Journal cover image

Allogeneic marrow transplantation.

Publication ,  Journal Article
Sullivan, KM; Storb, R
Published in: Cancer Invest
1984

After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.

Duke Scholars

Published In

Cancer Invest

DOI

ISSN

0735-7907

Publication Date

1984

Volume

2

Issue

1

Start / End Page

27 / 38

Location

England

Related Subject Headings

  • Transplantation, Homologous
  • Transplantation Immunology
  • Oncology & Carcinogenesis
  • Leukemia, Myeloid
  • Leukemia, Lymphoid
  • Leukemia
  • Immunosuppression Therapy
  • Immunologic Deficiency Syndromes
  • Humans
  • Histocompatibility Testing
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sullivan, K. M., & Storb, R. (1984). Allogeneic marrow transplantation. Cancer Invest, 2(1), 27–38. https://doi.org/10.3109/07357908409020284
Sullivan, K. M., and R. Storb. “Allogeneic marrow transplantation.Cancer Invest 2, no. 1 (1984): 27–38. https://doi.org/10.3109/07357908409020284.
Sullivan KM, Storb R. Allogeneic marrow transplantation. Cancer Invest. 1984;2(1):27–38.
Sullivan, K. M., and R. Storb. “Allogeneic marrow transplantation.Cancer Invest, vol. 2, no. 1, 1984, pp. 27–38. Pubmed, doi:10.3109/07357908409020284.
Sullivan KM, Storb R. Allogeneic marrow transplantation. Cancer Invest. 1984;2(1):27–38.
Journal cover image

Published In

Cancer Invest

DOI

ISSN

0735-7907

Publication Date

1984

Volume

2

Issue

1

Start / End Page

27 / 38

Location

England

Related Subject Headings

  • Transplantation, Homologous
  • Transplantation Immunology
  • Oncology & Carcinogenesis
  • Leukemia, Myeloid
  • Leukemia, Lymphoid
  • Leukemia
  • Immunosuppression Therapy
  • Immunologic Deficiency Syndromes
  • Humans
  • Histocompatibility Testing